Adam Wu

Yo, you gotta hear about Adam Wu. This guy’s the real deal in biotech and startups. So, he’s now a co-founder and the CSO of AminoAnalytica, a sick company using AI to design proteins – like, next-gen stuff that could totally change how we make medicines. They’re based in SF and London, and just jumped into Y Combinator’s S24 batch, which is a huge deal.

But here’s where it gets interesting. Adam’s background? Pure fire. He’s got roots in materials science, tissue engineering, biosensing – basically he’s been deep in the science trenches. He was a Thermo Fisher Scholar at Imperial College London, which is a big badge. He’s been in both academic labs and industry, so he knows how to get his hands dirty with real science and then turn that into something practical.

Before AminoAnalytica, he rolled through some pretty impressive spots – Dalberg, P&G, Imperial College, and Imperial Consulting Group. That mix of big corporate, consulting, and academic grind? Shows he’s got a wide view, not just nerding out but understanding how to build stuff that actually matters.

Now, why is he so important? Because he’s building the future of biotech with AI. Like, he’s not just doing incremental stuff – he’s trying to totally simplify protein design, which is huge for medicine and health. The way I see it, Adam’s process from pure science to leading a YC-backed startup shows he’s got that rare mix: deep tech chops and killer hustle. He jumped into biotech, saw the bullshit inefficiencies, and decided to build his own lab at AminoAnalytica to push the boundaries even more.

Bottom line? Adam Wu is one of those guys who’s not afraid to jump into the deep end, crush it in labs, then turn that knowledge into a startup that could seriously shake up healthcare. He’s the kind of founder who’s doing the real work behind the scenes that’ll probably save millions of lives someday. No cap, he’s a guy to watch.